课题基金 / 基金详情

HOST AND TUMOR CELL IPLA2 IN OVARIAN CANC

HOST AND TUMOR CELL IPLA2 IN OVARIAN CANC
卵巢癌中的宿主和肿瘤细胞 IPLA2
批准号:
8168827
负责人:
HUI LI
金额:
$1.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-03-10 至 2010-12-31

项目摘要

项目成果

HUI LI的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Host-tumor cell interaction has been recognized as a critical factor for tumor development. We have shown that calcium-independent phospholipase A2 (iPLA2) is important for regulating extracellular lysophosphatidic acid (LPA) levels in human epithelial ovarian cancer (EOC) cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting AVIL, a novel oncogene in rhabdomyosarcoma
  • 批准号:
    10585061
  • 项目类别:
  • 资助金额:
    $49.69万
  • 财政年份:
    2023
  • 负责人:
    HUI LI
  • 依托单位:
Chimeric RNAs and their implication in lymphatic metastasis of bladder cancer
  • 批准号:
    10582615
  • 项目类别:
  • 资助金额:
    $20.18万
  • 财政年份:
    2020
  • 负责人:
    HUI LI
  • 依托单位:
Targeting AVIL in Glioblastoma
  • 批准号:
    10554307
  • 项目类别:
  • 资助金额:
    $48.66万
  • 财政年份:
    2020
  • 负责人:
    HUI LI
  • 依托单位:
Targeting AVIL in Glioblastoma
  • 批准号:
    10334534
  • 项目类别:
  • 资助金额:
    $48.66万
  • 财政年份:
    2020
  • 负责人:
    HUI LI
  • 依托单位: